Financial Results, Monthly Sales Report, and Exclusive Holiday Offer - Research Report on Vitamin Shoppe, Rite Aid, Five Below, CST Brands, and PharMerica Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, November 8, 2013 NEW YORK, November 8, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting Vitamin Shoppe, Inc. (NYSE: VSI), Rite Aid Corporation (NYSE: RAD), Five Below, Inc. (NASDAQ: FIVE), CST Brands, Inc. (NYSE: CST), and PharMerica Corporation (NYSE: PMC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Vitamin Shoppe, Inc. Research Report On November 5, 2013, Vitamin Shoppe, Inc. (Vitamin Shoppe) released its Q3 FY 2013 (period ended September 28, 2013) results with net sales of $272.5 million representing 14.0% YoY increase. The Company's net income declined by 0.1% YoY to $16.3 million and diluted EPS stood at $0.53 down 1.9% YoY during the quarter. The Company stated that it opened 10 stores in the quarter and 33 new stores during 9M 2013. Tony Truesdale, CEO of Vitamin Shoppe, commented, "We delivered our 32nd consecutive quarter of positive comparable retail store sales growth and experienced improving traffic trends throughout the quarter. We opened a new 311,000 square foot distribution center in Ashland, VA and continued to successfully integrate Super Supplements, the largest acquisition in the company's history." The Company stated that for full-Year 2013, it expects low- to mid-single digit comparable store sales growth and plans to open approximately 50 new stores and; and for full-year 2014, Vitamin Shoppe anticipates mid single digit comparable store sales growth and intends to open approximately 60 new stores. The Full Research Report on Vitamin Shoppe, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCrorner.com/r/full_research_report/5327_VSI] -- Rite Aid Corporation Research Report On October 31, 2013, Rite Aid Corporation (Rite Aid) announced sales results for October 2013 (four-week period ended October 26, 2013). The Company registered total drugstore sales of $2.0 billion, up 2.2% YoY and same store sales increased 2.1% YoY. The Company reported that prescription sales accounted for 69.1% of drugstore sales and third party prescription sales represented 97.0% of pharmacy sales in October 2013. For the 34-week period ended October 26, 2013, Rite Aid posted total drugstore sales of $16.4 billion, down 0.3% YoY and same store sales decreased 0.1% YoY. The Full Research Report on Rite Aid Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/f64e_RAD] -- Five Below, Inc. Research Report On November 4, 2013, Five Below, Inc. (Five Below) unveiled its annual list of the Hottest Teen Gifts for $5 (or Less!). Tom Vellios, CEO and Co-Founder of Five Below, said, "At Five Below we pride ourselves on staying up-to-the-minute on the latest shopping trends so that we can provide shoppers with hot products at unbeatable $1 to $5 values. This holiday season we have a broad, trend-right, and affordable selection of gifts for everyone on your shopping list. With our list of the 2013 Hottest Teen Gifts for $5 (or Less!) in hand, Five Below customers can be sure to find amazing gifts from headphones to nail polish and more." The Company stated that 2013 Hottest Teen Gifts for $5 (or Less!) list includes: Blast speaker, Mega candy banks, Full-size rubber band loom, Character ornaments, DJ-style headphones, iPhone and Samsung Galaxy two-ply tuff cases, Infinity scarves, Bare and smoky eye palettes, Three-piece bath and body gift set, and Wham-O remote control monster trucks and rad racers. The Full Research Report on Five Below, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/31b8_FIVE] -- CST Brands, Inc. Research Report On November 4, 2013, CST Brands, Inc. (CST Brands) released its Q3 2013 results. CST Brands registered operating revenues of $3.3 billion, compared to $3.4 billion in Q3 2012. The Company posted net income of $41.0 million or $0.55 per diluted share compared with $24.0 million or $0.31 in Q3 2012. Kim Bowers, Chairman and CEO of CST Brands, stated, "We continue to make great strides as a separate, publicly-traded company, working on key initiatives such as establishing our culture, further developing our brand, and reducing and eliminating the transition services being provided by our former parent company. I am very proud of our hardworking team members across the company that helped produce a very solid quarter." The Full Research Report on CST Brands, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/2b19_CST] -- PharMerica Corporation Research Report On November 5, 2013, PharMerica Corporation (PharMerica) reported its Q3 2013 results with revenues at $436.8 million compared to $442.0 million in Q3 2012. The Company posted net loss of $6.2 million or $0.21 per diluted share, compared to net income of $6.0 million or $0.20 per diluted share in Q3 2012. Greg Weishar, PharMerica's CEO, said, "Sales productivity continues to improve and we are poised to achieve the goal of organic growth in the near future. Our superior cost containment programs, pharmacy services and industry-leading generic dispensing rate of 83.3% position the Company to further improve client retention and aggressively compete for market share in the long term care market." For full-year 2013, the Company revised its revenue guidance to be between $1.70 billion and $1.73 billion. The Full Research Report on PharMerica Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/b04b_PMC] ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. AnalystsCorner.com SOURCE Analysts' Corner Contact: Joe Thomas, CONTACT PHONE: +1-310-496-8071 (North America)
Financial Results, Monthly Sales Report, and Exclusive Holiday Offer - Research Report on Vitamin Shoppe, Rite Aid, Five Below,
Press spacebar to pause and continue. Press esc to stop.